Clinical Trials Logo
  1. Home
  2. Esophageal Varices
  3. NCT06017102
  4. Details
NCT06017102 Clinical Trial

Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices

Esophageal Varices Clinical Trial

Official title:
Difference in Aerosol-generating Amount Between Wired Magnetic-assisted Capsule Endoscopy System and Esophagogastroduodenoscopy Examination of Varices in Biliary Atresia Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06017102
Other study ID # 202210059DIPA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 5, 2023
Est. completion date December 31, 2024

Study information
Verified date November 2023
Source National Taiwan University Hospital
Contact Jia-Feng Wu, PhD
Phone +886 23123456
Email wjf@ntu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the safeness and effectiveness of traditional esophagogastroduodenoscope (EGD) and wired magnetically assisted capsule endoscopy (MACE) in the diagnosis of esophageal varices in biliary atresia (BA) patients. The main questions it aims to answer are: - Subjects who do wired magnetically assisted capsule endoscopy do not need to open the mouths during the process, this study also want to know whether wired magnetically assisted capsule endoscopy can reduce the generation of droplets. - Diagnostic accuracy between traditional esophagogastroduodenoscope and wired magnetically assisted capsule endoscopy in biliary atresia patients with esophageal varices. Participants will do either traditional esophagogastroduodenoscope or wired magnetically assisted capsule endoscopy.

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years and older
Eligibility Inclusion Criteria: - Biliary atresia patients > 6 years old - Vital signs are stable - Without acute gastrointestinal bleeding Exclusion Criteria: - Patients with metal implants, metal stent, artificial joints, bone plates, and bone screw - Patients with electronic devices, such as pacemakers, cochlear implants, or other implanted electronic medical devices - Throat or esophageal obstruction leading to dysphagia patients - Consciousness disturbance patients unable to swallow - Patients with acute upper gastrointestinal bleeding - Patients with platelet lower than 40K or PT INR > 1.5

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• wired magnetic assisted capsule endoscopy
once
• esophagogastroduodenoscopy
once

Locations
Country Name City State
Taiwan National Taiwan University Hospital Taipei City

Sponsors (2)
Lead Sponsor Collaborator
National Taiwan University Hospital Insight Medical Solutions

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Aerosol-generating amount 1-2 days
See also
  Status Clinical Trial Phase
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Recruiting NCT03989973 - Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
Completed NCT05485714 - Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
Completed NCT01851252 - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy Phase 1
Completed NCT01360515 - A Study of Disposable Transnasal Esophagoscope N/A
Recruiting NCT04602663 - Optimal Time for Follow up After Variceal Band Ligation N/A
Recruiting NCT04499898 - Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding Phase 2/Phase 3
Completed NCT00331188 - Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Phase 3
Enrolling by invitation NCT02767206 - Evaluation of Gastroesophageal Varices by Transnasal Endoscopy. N/A
Enrolling by invitation NCT05781828 - Noninvasive Methods For Prediction of Esophageal Varices in Children
Not yet recruiting NCT05199038 - Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study Phase 4
Recruiting NCT02740166 - Preventing Recurrent Bleeding After Eradication of Esophageal Varices Phase 4
Completed NCT01893541 - PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Phase 4
Terminated NCT00485290 - Effect of Meal on Portal and Esophagus Variceal Pressure N/A
Completed NCT01079416 - Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices N/A
Completed NCT01188733 - Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis Phase 1/Phase 2
Not yet recruiting NCT04254822 - HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients N/A
Recruiting NCT03212872 - Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding N/A
Completed NCT03748563 - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis N/A
Completed NCT01059396 - Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal Phase 4